sponsored content December 4, 2025 By Dr. Jason Shen, Director of Vision Science Research, North America, EssilorLuxottica Dr. Björn Drobe – Director,...
Meet Essilor® Stellest® lenses, the first and only FDA market authorized spectacle lens to slow myopia progression in children.*1 Click here to...
November 25, 2025 By Rana Zargar, OD My journey in myopia management began early in my career, driven by my passion for...
November 6, 2025 PARIS, France — EssilorLuxottica announced the Essilor Stellest 2.0 lenses at the China International Import Expo (CIIE) in Shanghai....
November 1, 2025 By Kevin Chan, OD, MS, FAAO, IACMM Dancing in the Storm The advent of Essilor’s Stellest lens as the...
U.S. eye care professionals can expect the Essilor Stellest lenses to be available in the coming weeks. September 26, 2025 PARIS, France...
Celebrating decades of science-driven progress and global impact during Myopia Awareness Week 2025 sponsored content May 20, 2025 Interview led by Shilpa...
April 16, 2025 PARIS, France — At the 2025 China Optometry & Ophthalmology Conference (COOC), EssilorLuxottica shared the six-year data from the...
sponsored content December 16, 2024 Insights from EssilorLuxottica’s Research at the International Myopia Conference 2024: Part I (click here for Part II)...
May 2, 2024 CANADA — EssilorLuxottica’s Stellest spectacle lenses for myopia management will be available in sun tints in Canada starting on...
August 15, 2023 VANCOUVER — At THE Myopia Meeting held here June 11, 2023, Jason Shen, PhD, FAAO, presented the clinical review...
November 9, 2022 TORONTO – With Canada the first country to establish myopia management as the standard of care and offering more...
April 29, 2022 CHARENTON-LE-PONT, France — Results of new research entitled “Progression of myopia with novel myopia control spectacle lenses“ will be...
December 2, 2021 MONTREAL — Essilor announced that several myopia management solutions will become available in Canada in early 2022. This marks...
sponsored content November 1, 2021 By Mark Bullimore, MCOptom, PhD, FAAO Effective spectacle options for myopia control have finally arrived. They are...
May 17, 2021 CHARENTON-LE-PONT, France — The U.S. Food and Drug Administration (FDA) granted Essilor’s Stellest lenses the Breakthrough Device designation. With...
April 9, 2021 CHARENTON-LE-PONT, France – After two years of a planned three-year clinical trial that tested the efficacy of Essilor’s Stellest...
March 3, 2021 Rick Gadd, President, Essilor North America, recently met with Review of Myopia Management’s Editor-in-Chief John Sailer to discuss the company’s...
March 3, 2021 Last month, CooperCompanies and EssilorLuxottica announced that they were teaming up to acquire SightGlass Vision. The goal of the joint...
February 3, 2021 SAN RAMON, Calif. and CHARENTON-LE-PONT, France – CooperCompanies and EssilorLuxottica entered a joint venture agreement to accelerate commercialization of...
January 1, 2021 By Krupa Philip, PhD, Brien Holden Vision Institute Although 2020 is a year that many will consider as best...
November 1, 2020 By Thomas Aller, OD, FBCLA Collaborator, BHVI With the increasing incidence of myopia all around the world, predictions of...
September 28, 2020 Interim findings after one year of an ongoing clinical trial of Essilor’s Stellest lens show more than 60% slowdown...